Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 26;11(8):e1414.
doi: 10.1002/cti2.1414. eCollection 2022.

Sex-bias in CD8+ T-cell stemness and exhaustion in cancer

Affiliations

Sex-bias in CD8+ T-cell stemness and exhaustion in cancer

Tabinda Hussain et al. Clin Transl Immunology. .

Abstract

This commentary article highlights two recently published studies, which for the first time revealed the immunological underpinnings of sex-bias in cancer incidence and mortality. These studies showed that the androgen receptor restrains anti-tumour immunity in males by repressing cytotoxic genes in CD8+ T cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Impact of androgen receptor (AR) signalling on the differentiation of intratumoural CD8+ T cells. Naïve CD8+ T cells upon tumour antigen encounter proliferate and differentiate into effector cells that produce IFN‐γ, TNF and GzmB. Upon prolonged antigen stimulation as in tumours, CD8+ T cells acquire an exhausted phenotype, marked by low expression of cytotoxic molecules and elevated expression of the inhibitor molecule PD‐1. Tumour‐reactive CD8+ T cells also contain stem‐like cells, which require expression of TCF1 and act as precursors for exhausted CD8+ T cells. AR signalling suppresses expression of TCF1 to restrain the differentiation of stem‐like CD8+ T cells while also repressing Ifng and Gzmb, thereby limiting the differentiation of effector T cells (in the box).

References

    1. Wilkinson NM, Chen HC, Lechner MG, Su MA. Sex differences in immunity. Annu Rev Immunol 2022; 40: 75–94. - PMC - PubMed
    1. Takahashi T, Ellingson MK, Wong P et al. Sex differences in immune responses that underlie COVID‐19 disease outcomes. Nature 2020; 588: 315–320. - PMC - PubMed
    1. Haupt S, Caramia F, Klein SL, Rubin JB, Haupt Y. Sex disparities matter in cancer development and therapy. Nat Rev Cancer 2021; 21: 393–407. - PMC - PubMed
    1. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol 2016; 16: 626–638. - PubMed
    1. Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol 2010; 10: 594–604. - PubMed